ADUCANUMAB

Course overview

ADUCANUMAB IS A MEDICATION USED IN THE MANAGEMENT AND TREATMENT OF ALZHEIMER'S DISEASE. IT IS AN AMYLOID BETA-DIRECTED MONOCLONAL ANTIBODY. THIS ACTIVITY DESCRIBES THE INDICATIONS, ACTION, AND CONTRAINDICATIONS FOR ADUCANUMAB AS A VALUABLE AGENT IN THE MANAGEMENT OF ALZHEIMER DISEASE. THIS ACTIVITY WILL HIGHLIGHT THE MECHANISM OF ACTION, ADVERSE EVENT PROFILE, AND OTHER KEY FACTORS (E.G., OFF-LABEL USES, DOSING, PHARMACODYNAMICS, PHARMACOKINETICS, MONITORING, RELEVANT INTERACTIONS) PERTINENT FOR MEMBERS OF THE INTERPROFESSIONAL TEAM IN THE MANAGEMENT OF PATIENTS WITH ALZHEIMER DISEASE.